Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14272622 | 0.75 | TSHR (0.39) | ESR1NAAATSHRTP53CYP3A4 | |
| SCHEMBL1534187 | 0.71 | TSHR (0.36) | ESR1NAAATSHRTP53CYP3A4 | |
| SCHEMBL6749851 | 0.70 | ALDH1A1 (0.38) | ESR1NAAATSHRTP53CYP3A4 | |
| SCHEMBL4230578 | 0.69 | ALDH1A1 (0.37) | ESR1NAAATSHRTP53CYP3A4 | |
| SCHEMBL818550 | 0.67 | TSHR (0.50) | ESR1TSHRTP53CYP3A4MAPK1 | |
| SCHEMBL4192255 | 0.66 | NAAA (0.40) | ESR1NAAATSHRTP53CYP3A4 | |
| SCHEMBL818740 | 0.66 | ALDH1A1 (0.51) | ESR1TSHRTP53CYP3A4MAPK1 | |
| SCHEMBL16086360 | 0.66 | NAAA (0.50) | NAAATSHRTP53CYP3A4MAPK1 | |
| SCHEMBL17048755 | 0.65 | NAAA (0.46) | NAAATSHRTP53CYP3A4MAPK1 | |
| SCHEMBL14967650 | 0.65 | TSHR (0.46) | NAAATSHRTP53CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008126971-A1 | POLYMER NANO PARTICLE CONTAINING UV BLOCKING MATERIAL AND METHOD FOR PREPARING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2008-10-23 | — | — | WO | claimed |
| CN-116725903-A | Cosmetic base, cosmetic comprising same, and water-in-oil type sunscreen cosmetic | 日油株式会社 | 2023-09-12 | — | — | CN | disclosed |
| WO-2008126971-A1 | POLYMER NANO PARTICLE CONTAINING UV BLOCKING MATERIAL AND METHOD FOR PREPARING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2008-10-23 | — | — | WO | disclosed |
| EP-0887070-B1 | External composition for skin comprising sphingoglycolipid | KIBUN FOOD CHEMIFA (JP) | 2004-12-22 | — | — | EP | disclosed |
| US-6514744-B2 | Skin moisturizer | KIBUN FOOD CHEMIFA CO., LTD. (JP) | 2003-02-04 | — | — | US | disclosed |
| US-20020164351-A1 | External compositions for skin comprising sphingoglycolipid | KIBUN FOOD CHEMIFA CO., LTD. (JP) | 2002-11-07 | — | — | US | disclosed |
| US-6348201-B2 | SPHINGOGLYCOLIPID AVAILABLE AS COSMETIC AND MEDICINE, HAS POTENT MOISTURIZING EFFEACT AND PREVENTIVE EFFECT AGAINST SKIN ROUGHNESS; SPHINOGGLYCOLIPID CONTAINING SUGAR MOITIES AND AMIDE GROUP | KIBUN FOOD CHEMIFA CO., LTD. (JP) | 2002-02-19 | — | — | US | disclosed |
| US-20020006414-A1 | EXTERNAL COMPOSITION FOR SKIN COMPRISING SPHINGOGLYCOLIPID | FOODCHEMIFA CO., LTD. (JP) | 2002-01-17 | — | — | US | disclosed |
| EP-0887070-A1 | External composition for skin comprising sphingoglycolipid | Kibun Food ChemiFA Co., Ltd. (JP) | 1998-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020164351-A1 | External compositions for skin comprising sphingoglycolipid | UGCG, UGGT1, MAN1B1 | ESR1 4778/4885NAAA 723/4885TSHR 4080/4885 |
| US-20020006414-A1 | EXTERNAL COMPOSITION FOR SKIN COMPRISING SPHINGOGLYCOLIPID | UGCG, MAN2A1, GALK1 | ESR1 4718/4885NAAA 541/4885TSHR 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.